Cardiovascular risk and diabetes in old people

British Journal of Diabetes and Vascular Disease

Volumn 5, Issue 1, 2005, Pages 7-11

  Rodriguez Mañas, Leocadio ^a   Castro, Marta ^b   Manzarbeitia, Jorge ^b  

^a HOSPITAL UNIVERSITARIO DE GETAFE   (Spain)

^b NONE

Author keywords

Cardiovascular disease; Cardiovascular risk; Risk tables

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN;

AGED; AMPUTATION; BLINDNESS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY FAILURE; DEMOGRAPHY; DIABETES MELLITUS; DIABETIC FOOT; DISEASE ASSOCIATION; HEART FAILURE; HUMAN; HYPERCHOLESTEROLEMIA; ISCHEMIC HEART DISEASE; KIDNEY TRANSPLANTATION; MULTIINFARCT DEMENTIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; REVIEW; RISK FACTOR; SEXUAL DYSFUNCTION; STROKE; VISUAL IMPAIRMENT;

EID: 14844353281     PISSN: 14746514     EISSN: None     Source Type: Journal    
DOI: 10.1177/14746514050050010201     Document Type: Review

References (57)

1. Gregg EW, Mangione CM, Cauley JA et al. Diabetes and incidence of functional disability in older women. Diabetes Care 2002;25:61-7.
2. Gregg EW, Yaffe K, Cauley JA et al. Is diabetes associated with cognitive impairment and cognitive decline among older women? Study of Osteoporotic Fractures Research Group. Arch Intern Med 2000;160: 174-80.
3. Gavard JA, Lustman PJ, Clouse RE. Prevalence of depression in adults with diabetes. An epidemiological evaluation. Diabetes Care 1993;16: 1167-78.
4. Nichols GA, Hillier TA, Erbey JR, Brown JB. Congestive heart failure in type 2 diabetes. Diabetes Care 2001;24:1614-19.
5. Barzilay JI, Spiekerman CF, Kuller LH et al. Prevalence of clinical and isolated subclinical cardiovascular disease in older adults with glucose disorders. The Cardiovascular Health Study. Diabetes Care 2001;24:1233-9.
6. Meneilly GS, Tessier D. Diabetes in elderly adults. J Gerontol Med Sci 2001;56A:M5-M13.
7. Henry P, Thomas F, Benetos A, Guize L. Impaired Fasting Glucose, blood pressure and cardiovascular disease mortality. Hypertension 2002;40: 458-63.
8. American Diabetes Association. 2003 Clinical Practice Recommendations. Diabetes Care 2003;26(suppl 1):S83-S86.
9. Wilson PWF, D'Agostino RB, Levy D et al. Prediction of coronary heart disease using risk factor categories. Circulation 1998;97:1837-47.
10. Colhoun HM, Betteridge DJ, Durrington PN et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet 2004; 364:685-96.
11. Garg A. Statins for all patients with type 2 diabetes: not so soon. Lancet 2004;364:641-2.
12. Snow V, Aronson MD, Hornbake ER, Mottur-Pilson C, Weiss KB for the Clinical Efficacy Assessment Subcommittee of the American College of Physicians. Lipid control in the management of Type 2 Diabetes Mellitus: a clinical practice guideline for the American College of Physicians. Ann Intern Med 2004;140:644-9.
13. Grundy SM, Cleeman JI, Merz CNB et al. for the Coordinating Committee of the National Cholesterol Education Program. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Circulation 2004;110:227-39.
14. Haffner SM, Lehto S, Rönnemaa T et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998;339:229-34.
15. Evans JMM, Wang J, Morris AD. Comparisons of cardiovascular risk between patients with type 2 diabetes and those who had had a myocardial infarction: cross sectional and cohort studies. BMJ 2002;324: 1-5.
16. Lee CD, Folsom AR, Pankow JS, Brancati FL for the Atherosclerosis Risk in Communities (ARIC) Study Investigators. Circulation 2004;109:855-60.
17. Ho JE, Paultre F, Mosca L. Is diabetes mellitus a cardiovascular disease risk equivalent for fatal stroke in women? Data from the Women's Pooling Project. Stroke 2003;34:2812-16.
18. Grundy SM, Howard B, Smith S Jr, Eckel R, Redberg R, Bonow RO. AHA Conference Proceedings. Prevention Conference VI: Diabetes and Cardiovascular Disease. Executive Summary. Conference Proceeding for Healthcare Professionals from a Special Writing Group of the American Heart Association. Circulation 2002;105:2231-9.
19. Newman AB, Gottdiener JS, McBurnie MA, et al. Associations of sub-clinical cardiovascular disease with frailty. J Gerontol 2001;56A:M158-M166.
20. Sinclair AJ, Cromme PVM, Rodríguez-Mañas L, Fasching P, Muggeo M, Hader C for the European Diabetes Working Party for Older People. Clinical Guidelines for Type 2 Diabetes Mellitus. http://www.euroage-diabetes.com
21. Ferrucci L, Furberg CD, Penninx BWJH et al. Treatment of isolated systolic hypertension is most effective in older patients with high-risk profile. Circulation 2001;104:1923-6.
22. Blaum CS, Ofstedal MB, Langa KM, Wray LA. Functional status and health outcomes in older Americans with diabetes mellitus. J Am Geriatr Soc 2003;51:745-53.
23. Stevens RJ, Kothari V, Adler AI, Stratton IM; United Kingdom Prospective Diabetes Study (UKPDS) Group. The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56). Clin Sci (Lond) 2001;101:671-9.
24. Kothari V, Stevens RJ, Adler AI et al. for the UK Prospective Diabetes Study. UKPDS 60. Risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study Risk Engine. Stroke 2002;33:1776-81.
25. Stevens RJ, Coleman RL, Adler AI, Stratton IM, Mathews DR, Holman RR. Risk factors for myocardial infarction case fatality and stroke case fatality in type 2 diabetes. UKPDS 66. Diabetes Care 2004;27:201-07.
26. Grundy SM, D'Agostino RB, Mosca L et al. Cardiovascular risk assessment based on US cohort studies. Findings from a National Heart, Lung, and Blood Institute Workshop. Circulation 2001; 104 491-6.
27. Menotti A, Lanti M, Puddu PE, Kromhout D. Coronary heart disease incidence in northern and southern European populations: a reanalysis of the seven countries study for a European coronary risk chart. Heart 2000; 84:238-44.
28. Ramachandran S, French JM, Vanderpump MPJ, Croft P, Neary RH. Using the Framingham model to predict heart disease in the United Kingdom: retrospective study. BMJ 2000;320:676-7.
29. Elias PK, Elias MF, D'Agostino RB et al. NIDDM and blood pressure as risk factors for poor cognitive performance. The Framingham Study. Diabetes Care 1997;20:1388-95.
30. Lowe LP, Tranel D, Wallace RB, Welty TK. Type II diabetes and cognitive function. A population-based study of Native Americans. Diabetes Care 1994;17:891-6.
31. Tariot PN, Ogden MA, Cox C, Williams TF. Diabetes and dementia in long term care. J Am Geriatr Soc 1999;47:423-9.
32. Scott RD, Kritz-Siverstein D, Barret-Connor E, Wiederholt WC. The association of non insulin dependent diabetes mellitus and cognitive function in an older cohort. J Am Geriatr Soc 1998; 46:1217-22
33. Ott A, Stolk RP, Hofman A, van Harskamp F, Grobbee DE, Breteler MM. Association of diabetes mellitus and dementia: the Rotterdam Study. Diabetologia 1996;39:1392-7.
34. Saaddine JB, Narayan KM, Engelgau MM, Aubert RE, Klein R, Beckles GL. Prevalence of self-rated visual impairment among adults with diabetes. Am J Public Health 1999;89:1200-05.
35. Trautner C, Icks A, Haastert B, Plum F, Berger M. Incidence of blindness in relation to diabetes. A population based study. Diabetes Care 1997; 20:1147-53.
36. el Rufaie OE, Bener A, Abuzeid MS, Ali TA. Sexual dysfunction among type II diabetic men: a comparative study. J Psychosom Res 1997;43: 605-12.
37. Bancroft, Gutiérrez F. Erectile dysfunction in men with and without diabetes mellitus: a comparative study. Diabet Med 1996;13:84-9.
38. Moss SE, Klein R, Klein BE. The 14-year incidence of lower extremity amputations in a diabetic population. The Wisconsin Epidemiologic Study of diabetic retinopathy. Diabetes Care 1999; 22:951-9.
39. Boyko EJ, Ahroni JH, Stensel V, Forsberg RC, Davignon DR, Smith DG. A prospective study of risk factors for diabetic foot ulcer. The Seattle diabetic foot study. Diabetes Care 1999;22 1036-42.
40. Ruggenenti P, Gambara V, Perna A, Bertani T, Remuzzi G. The nephropathy of non insulin dependent diabetes: predictors of outcome relative to diverse patterns of renal injury. J Am Soc Nephrol 1998;9:2336-43.
41. McMillan MA, Briggs JD, Junor BJ. Outcome of renal replacement treatment in patients wih diabetes mellitus. BMJ 1990;301:540-4.
42. Adler AI, Stratton IM, Neil HA et al. Association of systolic blood pressure with microvascular and macrovascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ 2000;321:412-19.
43. Amato S, Paolisso G, Cacciatore F et al. Congestive heart failure predicts the developement of NIDDM in the elderly. The observatore Geriatrico regione campania group. Diabetes Metab 1997;23:213-18.
44. Aronow WS, Ahn C, Gutstein H. Risk factors for a new atherotrombotic brain infarction in older african-american men and women. Am J Cardiol 1999;83:1144-5.
45. Adler AI, Neil HA, Manley SE, Holman RR, Turner RC. Hyperglicemia and hyperinsulinemia at diagnosis of diabetes and their association with subsequent cardiovascular disease in the U.K.P.D.S. (UKPDS 47). Am Heart J 1999;138:353-9.
46. De Marco R, Locatelli F, Zoppini G, Verlato G Bonora E, Muggeo M. Cause specific mortality in type 2 diabetes. The Verona Study. Diabetes Care 1999;22:756-61.
47. Lindeman RD, Romero LJ, Hudley R et al. Prevalence of type 2 diabetes, the insulin resistance syndrome, and coronary heart disease in an elderly biethnic population. Diabetes Care 1998; 21 959-66.
48. Jackson R. Updated New Zealand cardiovascular disease risk-benefit prediction guide. BMJ 2000;320:709-10.
49. Wood DA, Durrington P, McInnes G, Poulter N, Rees A, Wray R. Joint British recommendations on prevention of coronary heart disease in clinical practice. Heart 1998;80(suppl):S1-S29.
50. British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society, British Diabetic Association. Joint British recommendations on prevention of coronary heart disease in clinical practice: summary. BMJ 2000;320:705-08.
51. Haq IU, Jackson PR, Yeo WW, Ramsay LE. A comparison of methods for targeting CHD risk for primary prevention. Heart 1997;77(suppl 1):36.
52. Wallis EJ, Ramsay LE, Haq IU et al. Coronary and cardiovascular estimation for primary prevention: validation of a new Sheffield table in the 1995 Scottish health survey population. BMJ 2000;320:671-6.
53. Wood D, De BacKer G, Faergeman O, Graham I, Mancia G, Pyörälä K. Prevention of coronary heart disease in clinical practice. Recommendation of the Second Joint Task Force of European and other Societies on coronary prevention. European Society of Cardiology, European Atherosclerosis Society, European Society of Hypertension, International Society of Behavioural Medicine, European Society of General Practice/Family Medicine, European Heart Network. Eur Heart J 1998;19:1434-503.
54. Guidelines Subcommittee. World Health Organization-International Society of Hypertension. 1999 World Health Organization-International Society of Hypertension Guidelines for the management of hypertension. J Hypertens 1999;17:151-83.
55. Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Arch Intern Med 1997;157:2413-45.
56. Wilson PWF, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of Coronary Heart Disease using risk factor categories. Circulation 1998;97:1837-47.
57. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.